News Articles 131 - 140 of 160

News Type: BASL News

The 2019 ACCEA (Advisory Committee on Clinical Excellence Awards) round opens on Thursday 7th February 2019 and closes at 17:00 on Thursday 4th April 2019.

DEADLINE for applying for BASL support is 09:00 THURSDAY 7th MARCH 2019.

BASL will need to have completed the process of selecting those applicants who will receive our support well before the ACCEA deadline date.

If you wish to be considered for a national award in the 2019 round and you would like to seek BASL support, please complete and submit a copy of your ACCEA Application Form to BASL, along with any other supplementary CVQs; e.g. Research & Innovation (Form D), Teaching & Training (Form E), Medical Leadership & Managing a High Quality Service (Form F)

Applications should be sent to the BASL Secretariat to Judy Hawksworth at .

When submitting your application to BASL, please provide the name of an individual who has agreed to write your supporting citation. Please note: we will need to request a citation for every applicant even if the member is not successful in gaining BASL support, in order to meet the tight deadlines imposed by the ACCEA.

ACCEA regard the citations provided by BASL as important: they give added value to the process. The citation helps clarify information in the application and can put an individual's contribution into the wider context."

As in previous years BASL are able to support colleagues directly by nomination for national Gold, Silver and Bronze awards. As a specialist society, BASL cannot make nominations for Platinum awards; this must be done through the applicant’s University/Research Body and Universities UK. BASL can however provide a citation to support an application for a Platinum award.

How to apply for BASL support:

1. Send a copy of your completed ACCEA Application Form and other supplementary CVQs to the BASL Secretariat to by 09:00 on THURSDAY 7th March 2019. You must be a BASL member to request their support.

BASL also requires a short piece on your work with BASL and why you feel you should be supported by them. 

Please understand that in fairness to all applicants, late submissions will not be considered.

All applications are completed through the ACCEA on line system. The link to apply and downloadable copies of the application form and CVQ’s can be found on the ACCEA website and are intended to help those who wish to work on their application offline before completing them on the online system.  

Full application guidance can be found on the ACCEA website, including the use of the Supplementary Forms; 

2. When submitting your application to BASL, we ask that you provide the name and email address of an individual who has agreed to write your supporting citation upon sending your application. Please note: we will need to request a citation for every applicant even if the member is not successful in gaining BASL support, in order to meet the tight deadlines imposed by the ACCEA. 

3. Applications are scored independently by members of the BASL Committee.

4. If you are successful of BASL support then BASL will upload your citation to your application on the ACCEA website. It is your responsibility to ensure that you have completed your on line application to the ACCEA as per their instructions and regulations.

5. BASL will upload their supporting citations separately to their ranked lists. Individual scores are not submitted to the national panel but a ranked order for each award category is stated.

Should you have any questions, please do not hesitate to contact 

Clinics and Science in Hepatology - eLearning courses
News Type: BASL News

A series of free eLearning courses is now available online, based on the EACCME-accredited meeting ‘Clinics and Science in Hepatology’*, led by Course Directors Geoffrey Dusheiko and Maria Buti.

The courses are aimed at practising hepatologists, gastroenterologists and infectious disease specialists. Topics include:

  • Combating hepatitis C to reach elimination by 2030
  • Current management of HBV – focus on practical patient care
  • Current optimal management strategies for HBV
  • Management of HCV – current considerations

Visit to start a course and get your certificate.

Look out for more courses available online soon!

*EACCME accreditation for eLearning courses has been applied for. Decision pending.


NB: BASL have had no input into the eLearning course modules.


The 2019 Guts UK/BSPGHAN Awards are open for applications
News Type: BASL News

Two grants of up to £40,000 each are available for research studies on any topic within the spectrum of paediatric gastroenterology, hepatology and nutrition.
These awards are envisaged as development grants for the collection of pilot or proof-of-concept data that will enable a high-quality competitive application to be made subsequently to a research council or other large funder, such as the National Institute of Health Research (NIHR).

The grant call is open to clinician and scientist investigators, including Academic Clinical Lecturers, based at a UK university or hospital. The principal applicant must have a contract of sufficient length to cover the duration of the research project. At the time of applying the principal applicant must have their salary guaranteed for the entire period of the research project. This award is not for a fellowship; the principal applicant must not be a fellow though co-applicants may be. Funding will be available only in the UK. Only the direct costs associated with the project will be funded. Overhead allocation or other indirect costs, and salary of applicants which are already covered by other funding, will not be allowed. Equipment or capital costs will not be funded either. The maximum duration of the projects should be 24 months. 

For further information and to apply:

Deadline: 5pm 2nd April 2019. The awards will be announced in early June.

If you have any queries about these awards please contact: Alice Kington, Finance and Research Manager at Guts UK . Telephone: 020 7563 9994. E-mail: .

Guts UK/Dr Falk Awards - Application Deadline is 4th March 2019
News Type: BASL News

The Guts UK/Dr Falk Awards recognise the achievements of those who bring new insight to gastroenterology and hepatology, and the collaboration that furthers patient care. For those committed to furthering research or improving patient care these awards are an opportunity to achieve national recognition as well as the financial support for career progression. This year colleagues may nominate a nurse for the Nurse Prize.

Prizes available:
A £1,000 prize for the best essay on gastroenterology or hepatology research personally undertaken by medical students who were on an intercalated BSc/MRes/MSc/MPH/MBPhD* course during the previous academic year (2017/18)

Four £1,500 prizes for medical students taking full-time science degrees (BSc/MRes/MSc/MPH/MBPhD*) focusing on research into gastrointestinal or liver-related disease in the current academic year (2018/19)

Two £2,500 awards for F1/F2 doctors to facilitate prospective research in an area relevant to gastroenterology or hepatology

A £1,000 award for primary and secondary care gastrointestinal/liver nurses for initiatives that have advanced patient care

A £1,000 award for dietitians working in the gastrointestinal / liver field for initiatives that have advanced or improved patient care

SpR Trainee Audit/Quality Improvement Awards Up to £10,000 is available for UK-based gastroenterology / hepatology specialty trainees who would like to conduct an audit or quality improvement project in any area of gastroenterology, liver disease or nutrition.

The application deadline is 5pm on Monday 4th March 2019
Applications received after this time will not be considered.
For further information and to apply: 

* PhD students should note that they may apply for the medical student prize only once during their three-year studentship and that they may apply for the essay prize when their PhD has been completed.

3 Year Funded Clinical Research Fellow Post - Addenbrookes Hospital, Cambridge
News Type: BASL News

Applications are invited for a 3 year funded Clinical Research Fellow post for an individual to undertake a PhD in the field on non-alcoholic steatohepatitis (NASH) and regenerative medicine using state of the art techniques, working with Dr Michael Allison in the Liver Unit, Cambridge BRC, Addenbrooke’s Hospital, and Professor Ludovic Vallier at the MRC Stem Cell Institute and Sanger Centre. Applicants are expected to be at the Speciality Registrar level with previous Hepatology experience. Participation in the on-call Hepatology rota is essential at a frequency to be discussed. The successful applicant will also have the opportunity to attend all the educational opportunities the Liver Transplant Unit, the Cambridge Biomedical Research Centre and the Campus offers.

For further information, please contact Dr Michael Allison - .

Recruitment - Hepatology Fellow(s) - Princess Alexandra Hospital, Brisbane, Australia
News Type: BASL News

The Department of Gastroenterology and Hepatology at the Princess Alexandra Hospital, Brisbane, is recruiting Hepatology Fellow(s).

The successful candidate(s) should be completing advanced training in Gastroenterology/Hepatology and have a strong interest in clinical/basic research. The selected candidate will participate in outpatient clinical services for management of liver disease especially viral hepatitis and non-alcoholic fatty liver disease and will also contribute to the junior medical staff education program. Clinical research opportunities include many aspects of chronic liver disease, particularly related to NAFLD and integrated care. Basic research opportunities include investigation of liver repair/regeneration and innate immune function.

For further information or expressions of interest, please contact: Prof Elizabeth Powell, Director, Centre for Liver Disease Research and Hepatologist, Translational Research Institute on Tel No: 61 7 34438015 or .

The commencement is February 2019 however this is negotiable.

NICE - Subcutaneous automated low-flow pump implantation for refractory ascites caused by cirrhosis
News Type: BASL News

The final guidance for subcutaneous automated low-flow pump implantation for refractory ascites caused by cirrhosis is now available on the NICE website (November 2018) > 

IQILS Accreditation Scheme - update
News Type: BASL News

The IQILS accreditation scheme (Improving Quality in Liver Services) has now been operational for over a year. 2018 has been a busy year for the scheme, with 36 services registered to date.

A full list and map of those registered can be found on the website. Services across Wales, Northern Ireland and England are included in those registered. A few early bird discounts, available for smaller services, kindly supported by BASL, are still available. If your service would be interested in this, please get in touch at .

The second service training day for registered services is being held in London on 29 January 2019. The day is designed for services that would like to learn more about the accreditation standards and the accreditation process. For further information, please contact the team. 

Following an assessor training day held in September, the first batch of assessors have been recruited and trained. Wales is leading the way in improving liver services and with the help of an initiative funded by the Welsh government, with two peer review visits taking place in November 2018. The scheme is going from strength to strength and our hope is that we have more services registering with the scheme. Registration is open to all liver services across the UK.

For further information, please visit the IQILS website  or email  .

Election of Wilson’s Disease SIG lead
News Type: BASL News

BASL has set up a number of Special Interest Groups (SIGs), which are linked to the NIHR’s Clinical Research Network (CRN) topic areas. The Wilson’s Disease SIG has been active for one year, with an initial lead appointed by the BASL Committee. BASL is now seeking nominations for an elected Lead for this SIG. 

Eligibility requirements

  • All nominees should be members of the Wilson’s Disease SIG, as a BASL member or as an associate member of BASL through being a member of the SIG
  • Each nominee should have a proposer and seconder, who should also be BASL members or associate members through the Wilson’s Disease SIG
  • The initial Lead can stand for election once
  • Should a contested election be held, BASL / Wilson’s Disease SIG members may vote in this
  • The elected Lead will serve for two years, when there will be a further election.

Nomination process

  • Please send nominations to the BASL Secretariat at  by 17:00 on 19 November 2018
  • If more than one candidate is nominated, the Secretariat will arrange for an election, in which all BASL / Wilson’s Disease SIG members may vote
  • Should an election be required, candidates will need to submit a personal statement of up to 300 words
  • The successful candidate will be elected by a simple majority of those members voting
  • Any queries should be addressed to

About the Wilson’s Disease SIG

The Wilson’s Disease SIG is linked to the Metabolic CRN topic area. The  SIG comprises a variety of clinical and laboratory specialists from around the UK, Public Health England and patient representation from the Wilson’s Disease Support Group. Its aims are to foster closer collaboration for clinical and scientific research, provide a forum to discuss and disseminate best practice, and act as a stimulus towards Centres of Excellence for Wilson’s disease. Further information may be found here.

The role of the SIG Lead

A SIG is expected to meet at least once a year. The BASL secretariat provides administrative support for SIGs, which includes creating and maintaining SIG member databases, arranging meetings and associated materials, and arranging publicity.

The role of the SIG Lead includes:

  • Chairing SIG meetings and co-ordinating actions to be pursued
  • Helping to co-ordinate bids for funding for trials and other research, and linking with the NIHR and other funders
  • Ensuring the SIG is recognised and supported within the Metabolic CRN topic area
  • Reporting on SIG activities to BASL, in particular via liaison with BASL’s Research Subcommittee.

Cancer Analyst Required - Epidemiology of Cholangiocarcinoma in England
News Type: BASL News

Cancer Analyst for Analysis of the Epidemiology of Cholangiocarcinoma in England

Accountable to: AMMF/ PHE Senior Analyst
Hours: 37.5/week
Duration: One year fixed term
Location: Flexible across national bases but post holder must be able to travel to London on a regular basis
Pay Grade: £27,527 -­ £33,098 (+ London Weighting if appropriate)

AMMF is the UK’s only dedicated cholangiocarcinoma charity, and works closely with Cholangiocarcinoma-­UK (CCA-­UK), a multidisciplinary UK-­wide group interested in all facets of CCA and a Special Interest Group of BASL. AMMF is looking for a dedicated analyst with a strong statistical background and experience of routinely collected health data to work on an important epidemiological project on cholangiocarcinoma. This is an exciting opportunity to work on the most definitive study of cholangiocarcinoma epidemiology to date, in conjunction with AMMF, international experts in cholangiocarcinoma from Imperial College London and Public Health England’s (PHE) National Cancer Registration and Analysis Service (NCRAS).

Please email your CV together with a covering letter (max 500 words) to Helen Morement, CEO, AMMF at: For more information, please see:

Download CCA-Cancer Analyst Advert.pdf

Download CCA-Cancer-Analyst-Job Description_181018.pdf 

or visit AMMF’s website:

Closing date: 16 November 2018 at 5pm GMT

Interviews will be held w/c 3rd December 2018